Boston Scientific announced that it is looking to boost its bottom line in the Chinese market.
The company has seen revenues fall over the past year and is adding new employees in China as well as surgeon training centers. The company slashed several jobs in the United States to develop new projects and other initiatives. The company will seek more direct interaction with Chinese physicians.
More Articles on Devices:
First Navio Unicondylar Knee Replacement Performed in France
NuVasive Appoints Three Directors for European Device Market Leadership
Stryker Reaches Settlements in First Four Hip Lawsuits Filed in New Jersey